2606004393
  • Open Access
  • Review

Herbal Products in Diabetes Management: Therapeutic Potential, Clinical Relevance, and Regulatory Challenges

  • Swati Sahu,   
  • Umesh Kumar Patil *,   
  • Datta Maroti Pawde *

Received: 02 May 2026 | Revised: 20 Jun 2026 | Accepted: 23 Jun 2026 | Published: 30 Jun 2026

Abstract

The rising occurrence of diabetes mellitus is attributed to many factors. Despite the effectiveness of the latest therapeutic agents, long-term use has been affected by their side effects, expense, incompleteness and patient non-compliance. Herbal and plant-derived therapies, which were previously used traditionally, have gained much more interest as complementary or alternative approaches to diabetes mellitus treatment. Herbal medicine represents a complex mixture of numerous phytochemicals; the action of each phytochemical is associated with its potential to produce an antidiabetic effect through multiple methods. These methods include stimulating insulin release, increasing insulin sensitivity, inhibiting carbohydrate digestion, modifying glucose transporters, and decreasing oxidative stress. The purpose of this review is to comprehensively evaluate the use of herbal medicines in controlling diabetes, while also integrating both mechanistic and clinical studies. The pathophysiology of diabetes with the corresponding herbal treatment will also be reviewed, in order to provide an in-depth assessment of the methods of action of herbal medications. Additionally, we consider clinical significance of therapeutic uses for medicinal plants using both evidence-based and clinical data. This helps us to evaluate limitations and inherent problems, such as their inability to produce consistent results and variation in plant composition. We also assess regulatory limitations and restrictions that affect clinical applications and guide future implementation strategies for diabetes mellitus treatment.

 

References 

  • 1.

    Ojo, O.A.; Ibrahim, H.S.; Rotimi, D.E.; et al. Diabetes Mellitus: From Molecular Mechanism to Pathophysiology and Pharmacology. Med. Nov. Technol. Devices. 2023, 19, 100247. https://doi.org/10.1016/j.medntd.2023.100247.

  • 2.

    Sun, H.; Saeedi, P.; Karuranga, S.; et al. IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119.

  • 3.

    DeFronzo, R.A.; Ferrannini, E.; Groop, L.; et al. Type 2 Diabetes Mellitus. Nat. Rev. Dis. Primers 2015, 1, 15019. https://doi.org/10.1038/nrdp.2015.19.

  • 4.

    Atkinson, M.; Gharti, P.; Min, T. Metformin Use and Vitamin B12 Deficiency in People with Type 2 Diabetes: What Are the Risk Factors? A Mini-Systematic Review. touchREV Endocrinol. 2024, 20, 42–53. https://doi.org/10.17925/EE.2024.20.2.7.

  • 5.

    Kodur, N.; Sharew, B.; Lansang, M.C.; et al. Managing the Side Effects of Sodium–Glucose Cotransporter-2 Inhibitors. Cleve. Clin. J. Med. 2025, 92, 503–511. https://doi.org/10.3949/ccjm.92a.24071.

  • 6.

    Kunnumakkara, A.B.; Hegde, M.; Parama, D.; et al. Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials. ACS Pharmacol. Transl. Sci. 2023, 6, 447–518. https://doi.org/10.1021/acsptsci.2c00012.

  • 7.

    Pothuraju, R.; Sharma, R.K.; Chagalamarri, J.; et al. A Systematic Review of Gymnema sylvestre in Obesity and Diabetes Management. J. Sci. Food Agric. 2014, 94, 834–840. https://doi.org/10.1002/jsfa.6458.

  • 8.

    Uti, D.E.; Atangwho, I.J.; Alum, E.U.; et al. Natural Antidiabetic Agents: Current Evidence and Development Pathways from Medicinal Plants to Clinical Use. Nat. Prod. Commun. 2025, 20, 1934578X251323393. https://doi.org/10.1177/1934578X251323393.

  • 9.

    Hossain, C.M.; Gera, M.E.; Ali, K.A. Current Status and Challenges of Herbal Drug Development and Regulatory Aspect: A Global Perspective. Asian J. Pharm. Clin. Res. 2022, 15, 31–41. http://dx.doi.org/10.22159/ajpcr.2022v15i12.46134.

  • 10.

    McIntyre, H.D.; Catalano, P.; Zhang, C.; et al. Gestational Diabetes Mellitus. Nat. Rev. Dis. Primers 2019, 5, 47. https://doi.org/10.1038/s41572-019-0098-8.

  • 11.

    Dludla, P.V.; Mabhida, S.E.; Ziqubu, K.; et al. Pancreatic β-Cell Dysfunction in Type 2 Diabetes: Implications of Inflammation and Oxidative Stress. World J. Diabetes 2023, 14, 130–146. https://doi.org/10.4239/wjd.v14.i3.130.

  • 12.

    Dinić, S.; Arambašić Jovanović, J.; Uskoković, A. Oxidative Stress-Mediated Beta Cell Death and Dysfunction as a Target for Diabetes Management. Front. Endocrinol. 2022, 13, 1006376. https://doi.org/10.3389/fendo.2022.1006376.

  • 13.

    Wang, H.; Bai, R.; Wang, Y.; et al. The Multifaceted Function of FOXO1 in Pancreatic β-Cell Dysfunction and Insulin Resistance: Therapeutic Potential for Type 2 Diabetes. Life Sci. 2025, 364, 123384. https://doi.org/10.1016/j.lfs.2025.123384.

  • 14.

    Omale, S.; Amagon, K.I.; Johnson, T.O.; et al. A Systematic Analysis of Anti-Diabetic Medicinal Plants from Cells to Clinical Trials. PeerJ 2023, 11, e14639. https://doi.org/10.7717/peerj.14639.

  • 15.

    Parasuraman, S.; Thing, G.S.; Dhanaraj, S.A. Polyherbal Formulation: Concept of Ayurveda. Pharmacogn Rev. 2014, 8, 73–80. https://doi.org/10.4103/0973-7847.134229.

  • 16.

    Sachan, K.; Verma, S.; Arora, K.; et al. Traditional Herbal Medications Utilized in the Indian Medical System for the Management of Diabetes: An Updated Review and Clinical Implications. Curr. Diabetes Rev. 2024, 20, e230124226017. https://doi.org/10.2174/0115733998273029231121094725.

  • 17.

    Sen, D.B.; Balaraman, R.; Sen, A.K.; et al. Antidiabetic Activity of Herbal Remedies. J. Nat. Rem. 2023, 23, 373–381. https://doi.org/10.18311/jnr/2023/32182.

  • 18.

    Jiang, Y.; Yue, R.; Liu, G.; et al. Garlic (Allium sativum L.) in Diabetes and Its Complications: Recent Advances in Mechanisms of Action. Crit. Rev. Food Sci. Nutr. 2024, 64, 5290–5340. https://doi.org/10.1080/10408398.2022.2153793.

  • 19.

    Abo-Youssef, A.M.; Messiha, B.A. Beneficial Effects of Aloe vera in Treatment of Diabetes: Comparative In Vivo and In Vitro Studies. Bull. Fac. Pharm. Cairo Univ. 2013, 51, 7–11. https://doi.org/10.1016/j.bfopcu.2012.03.002.

  • 20.

    Pereira, A.S.; Banegas-Luna, A.J.; Peña-García, J.; et al. Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening. Molecules 2019, 24, 4030. https://doi.org/10.3390/molecules24224030.

  • 21.

    Medagama, A.B. The Glycaemic Outcomes of Cinnamon, a Review of the Experimental Evidence and Clinical Trials. Nutr. J. 2015, 14, 108. https://doi.org/10.1186/s12937-015-0098-9.

  • 22.

    Baby, N.; Kurian, A.M. Exploration and Validation of Anti-Diabetic Potential of Terpenoid Phytocompounds from Indian Traditional Medicinal Plant Gymnema sylvestre. In Silico Pharmacol. 2026, 14, 83. https://doi.org/10.1007/s40203-026-00573-z.

  • 23.

    Joseph, B.; Jini, D. Antidiabetic Effects of Momordica charantia (Bitter Melon) and Its Medicinal Potency. Asian Pac. J. Trop. Dis. 2013, 3, 93–102. https://doi.org/10.1016/S2222-1808(13)60052-3.

  • 24.

    Przeor, M. Some Common Medicinal Plants with Antidiabetic Activity, Known and Available in Europe (A Mini-Review). Pharmaceuticals 2022, 15, 65. https://doi.org/10.3390/ph15010065.

  • 25.

    Mashayekhi-Sardoo, H.; Sepahi, S.; Rahimi, V.B.; et al. Application of Nigella sativa as a Functional Food in Diabetes and Related Complications: Insights on Molecular, Cellular, and Metabolic Effects. J. Funct. Foods 2024, 122, 106518. https://doi.org/10.1016/j.jff.2024.106518.

  • 26.

    Patil, R.; Patil, R.; Ahirwar, B.; et al. Isolation and Characterization of Antidiabetic Component (Bioactivity-Guided Fractionation) from Ocimum sanctum L. (Lamiaceae) Aerial Part. Asian Pac. J. Trop. Med. 2011, 4, 278–282. https://doi.org/10.1016/S1995-7645(11)60086-2.

  • 27.

    Mammen, M. V.; Anand, A.; Mishra, A.; et al. Herbal plants as novel antidiabetic agents: Phytochemical profiles, mechanisms, and clinical evidence. Rev. Diabet. Stud. 2025, 21, 159–178. https://doi.org/10.1900/92fgeq25.

  • 28.

    Maruthupandian, A.; Mohan, V.R. Antidiabetic, Antihyperlipidaemic and Antioxidant Activity of Pterocarpus marsupium Roxb. in Alloxan Induced Diabetic Rats. Int. J. Pharm. Tech. Res. 2011, 3, 1681–1687.

  • 29.

    Vajdi, M.; Noshadi, N.; Bonyadian, A.; et al. Therapeutic Effect of Fenugreek Supplementation on Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Clinical Trials. Heliyon 2024, 10, e36649. https://doi.org/10.1016/j.heliyon.2024.e36649.

  • 30.

    Sukalingam, K.; Ganesan, K.; Ponnusamy, K. Evaluation of Antidiabetic Activity of Polyherbal Formulations on Type 2 Diabetic Patients: A Single Blinded Randomized Study. Int. J. Integr. Med. Sci. 2015, 2, 90–98.

  • 31.

    Suvarna, R.; Shenoy, R.P.; Hadapad, B.S.; et al. Effectiveness of Polyherbal Formulations for the Treatment of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. J. Ayurveda Integr. Med. 2021, 12, 213–222. https://doi.org/10.1016/j.jaim.2020.11.002.

  • 32.

    Ghanadian, M.; Taslimi, P. The Inhibitory Potential of Natural Compounds on α-Amylase and α-Glucosidase in the Management of Type 2 Diabetes. Iran. J. Chem. Chem. Eng. 2024, 43, 1905–1918.

  • 33.

    Fernandes, I.; Oliveira, J.; Pinho, A.; et al. The Role of Nutraceutical Containing Polyphenols in Diabetes Prevention. Metabolites 2022, 12, 184. https://doi.org/10.3390/metabo12020184.

  • 34.

    Wang, T.; Wang, Y.Y.; Shi, M.Y.; et al. Mechanisms of Action of Natural Products on Type 2 Diabetes. World J. Diabetes 2023, 14, 1603–1620. https://doi.org/10.4239/wjd.v14.i11.1603.

  • 35.

    Semwal, D.K.; Kumar, A.; Aswal, S.; et al. Protective and Therapeutic Effects of Natural Products against Diabetes Mellitus via Regenerating Pancreatic β-Cells and Restoring Their Dysfunction. Phytother. Res. 2021, 35, 1218–1229. https://doi.org/10.1002/ptr.6885.

  • 36.

    Wickramasinghe, A.S.; Kalansuriya, P.; Attanayake, A.P. Herbal Medicines Targeting the Improved β-Cell Functions and β-Cell Regeneration for the Management of Diabetes Mellitus. Evid. Based Complement. Alternat. Med. 2021, 2021, 2920530. https://doi.org/10.1155/2021/2920530.

  • 37.

    Papuc, C.; Goran, G.V.; Predescu, C.N.; et al. Plant Polyphenols Mechanisms of Action on Insulin Resistance and against the Loss of Pancreatic Beta Cells. Crit. Rev. Food Sci. Nutr. 2022, 62, 325–352. https://doi.org/10.1080/10408398.2020.1815644.

  • 38.

    Li, J.; Bai, L.; Wei, F.; et al. Therapeutic Mechanisms of Herbal Medicines against Insulin Resistance: A Review. Front. Pharmacol. 2019, 10, 661. https://doi.org/10.3389/fphar.2019.00661.

  • 39.

    Manukumar, H.M.; Shiva Kumar, J.; Chandrasekhar, B.; et al. Evidences for Diabetes and Insulin Mimetic Activity of Medicinal Plants: Present Status and Future Prospects. Crit. Rev. Food Sci. Nutr. 2017, 57, 2712–2729. https://doi.org/10.1080/10408398.2016.1143446.

  • 40.

    Rybak, M.; Wojdyło, A. Inhibition of α-Amylase, α-Glucosidase, Pancreatic Lipase, 15-Lipoxygenase and Acetylcholinesterase Modulated by Polyphenolic Compounds, Organic Acids, and Carbohydrates of Prunus domestica Fruit. Antioxidants 2023, 12, 1380. https://doi.org/10.3390/antiox12071380.

  • 41.

    Thilagam, E.; Parimaladevi, B.; Kumarappan, C.; et al. α-Glucosidase and α-Amylase Inhibitory Activity of Senna surattensis. J. Acupunct. Meridian Stud. 2013, 6, 24–30. https://doi.org/10.1016/j.jams.2012.10.005.

  • 42.

    Mata-Torres, G.; Andrade-Cetto, A.; Espinoza-Hernandez, F. Approaches to Decrease Hyperglycemia by Targeting Impaired Hepatic Glucose Homeostasis Using Medicinal Plants. Front. Pharmacol. 2021, 12, 809994. https://doi.org/10.3389/fphar.2021.809994.

  • 43.

    Mata-Torres, G.; Andrade-Cetto, A.; Espinoza-Hernández, F.A.; et al. Hepatic Glucose Output Inhibition by Mexican Plants Used in the Treatment of Type 2 Diabetes. Front. Pharmacol. 2020, 11, 215. https://doi.org/10.3389/fphar.2020.00215.

  • 44.

    Yang, H. Advances in Research on Lipid-Lowering Mechanisms of Eight Medicinal Plants. AIP Conf. Proc. 2019, 2058, 020007. https://doi.org/10.1063/1.5085520.

  • 45.

    Kim, Y.; Keogh, J.B.; Clifton, P.M. Polyphenols and Glycemic Control. Nutrients 2016, 8, 17. https://doi.org/10.3390/nu8010017.

  • 46.

    Grundy, S.M. Metabolic Syndrome Update. Trends Cardiovasc. Med. 2016, 26, 364–373. https://doi.org/10.1016/j.tcm.2015.10.004.

  • 47.

    Zafar, A.; Alruwaili, N.K.; Panda, D.S.; et al. Potential of Natural Bioactive Compounds in Management of Diabetes: Review of Preclinical and Clinical Evidence. Curr. Pharmacol. Rep. 2021, 7, 107–122. https://doi.org/10.1007/s40495-021-00255-8.

  • 48.

    Lankatillake, C.; Huynh, T.; Dias, D.A. Understanding Glycaemic Control and Current Approaches for Screening Antidiabetic Natural Products from Evidence-Based Medicinal Plants. Plant Methods 2019, 15, 105. https://doi.org/10.1186/s13007-019-0487-8.

  • 49.

    Janapati, Y.K.; Junapudi, S. Progress in Experimental Models to Investigate the In Vivo and In Vitro Antidiabetic Activity of Drugs. Anim. Model Exp. Med. 2024, 7, 297–309. https://doi.org/10.1002/ame2.12442.

  • 50.

    Hasan, M.M.; Ahmed, Q.U.; Soad, S.Z.; et al. Animal Models and Natural Products to Investigate In Vivo and In Vitro Antidiabetic Activity. Biomed. Pharmacother. 2018, 101, 833–841. https://doi.org/10.1016/j.biopha.2018.02.137.

  • 51.

    Abdul Majid, F.A.; Fadhlina, A.; Ismail, H.F.; et al. Mutagenicity and Safety Pharmacology of a Standardized Antidiabetic Polyherbal Formulation. Sci. Rep. 2022, 12, 7127. https://doi.org/10.1038/s41598-022-11243-3.

  • 52.

    Swaroop, A.; Bagchi, M.; Kumar, P.; et al. Safety, Efficacy and Toxicological Evaluation of a Novel, Patented Anti-Diabetic Extract of Trigonella foenum-graecum Seed Extract (Fenfuro). Toxicol. Mech. Methods 2014, 24, 495–503. https://doi.org/10.3109/15376516.2014.943443.

  • 53.

    Gupta, P.P.; Haider, J.; Yadav, R.P.; et al. Preclinical Evaluation of Antidiabetic Activity of Poly Herbal Plant Extract in Streptozotocin Induced Diabetic Rats. JPHYTO 2016, 5, 45–49.

  • 54.

    Thikekar, A.K.; Thomas, A.B.; Chitlange, S.S. Herb–Drug Interactions in Diabetes Mellitus: A Review Based on Pre-Clinical and Clinical Data. Phytother. Res. 2021, 35, 4763–4781. https://doi.org/10.1002/ptr.7108.

  • 55.

    Blonde, L.; Khunti, K.; Harris, S.B.; et al. Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician. Adv. Ther. 2018, 35, 1763–1774. https://doi.org/10.1007/s12325-018-0805-y.

  • 56.

    Ahmad, R.; AlLehaibi, L.H.; AlSuwaidan, H.N.; et al. Evaluation of Clinical Trials for Natural Products Used in Diabetes: An Evidence-Based Systematic Literature Review. Medicine 2021, 100, e25641. https://doi.org/10.1097/MD.0000000000025641.

  • 57.

    Farhadnejad, H.; Saber, N.; Neshatbini Tehrani, A.; K et al. Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies. J. Nutr. Metab. 2024, 2024, 8300428. https://doi.org/10.1155/2024/8300428.

  • 58.

    Mehrzadi, S.; Mirzaei, R.; Heydari, M.; et al. Efficacy and Safety of a Traditional Herbal Combination in Patients with Type II Diabetes Mellitus: A Randomized Controlled Trial. J. Diet. Suppl. 2021, 18, 31–43. https://doi.org/10.1080/19390211.2020.1727076.

  • 59.

    May, M.; Schindler, C. Clinically and Pharmacologically Relevant Interactions of Antidiabetic Drugs. Ther. Adv. Endocrinol. Metab. 2016, 7, 69–83. https://doi.org/10.1177/2042018816638050.

  • 60.

    Ebadi, A.G. Synergistic Approaches in Diabetes Management: The Role of Antidiabetic Drugs and Herbal Medicine in Therapeutic Strategies. Nepal J. Med. Sci. 2025, 10, 68–82. https://doi.org/10.3126/njms.v10i2.79012.

  • 61.

    Lian, F.; Tian, J.; Chen, X.; et al. The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial. PLoS ONE 2015, 10, e0130550. https://doi.org/10.1371/journal.pone.0130550.

  • 62.

    McBenedict, B.; Orfao, A.L.; Goh, K.S.; et al. The Role of Alternative Medicine in Managing Type 2 Diabetes: A Comprehensive Review. Cureus 2024, 16, e61965. https://doi.org/10.7759/cureus.61965.

  • 63.

    Bonikowska, I.; Szwamel, K.; Uchmanowicz, I. Analysis of the Impact of Disease Acceptance, Demographic, and Clinical Variables on Adherence to Treatment Recommendations in Elderly Type 2 Diabetes Mellitus Patients. Int. J. Environ. Res. Public Health 2021, 18, 8658. https://doi.org/10.3390/ijerph18168658.

  • 64.

    Rajesham, V.V.; Aparna, A.M.; Kalyani, P.; et al. Exploring Herbal Remedies for Diabetes Management: A Comprehensive Review of Efficacy, Epidemiology, and Quality of Life Considerations. Int. Res. J. Pharm. Med. Sci. 2024, 7, 67–73.

  • 65.

    Han, D.G.; Cho, S.S.; Kwak, J.H.; et al. Medicinal Plants and Phytochemicals for Diabetes Mellitus: Pharmacokinetic Characteristics and Herb–Drug Interactions. J. Pharm. Investig. 2019, 49, 603–612. https://doi.org/10.1007/s40005-019-00440-4.

  • 66.

    Gupta, R.C.; Chang, D.; Nammi, S.; et al. Interactions between Antidiabetic Drugs and Herbs: An Overview of Mechanisms of Action and Clinical Implications. Diabetol. Metab. Syndr. 2017, 9, 59. https://doi.org/10.1186/s13098-017-0254-9.

  • 67.

    Sahare, A.Y.; Akare, S.C.; Agrawal, R.B.; et al. Standardization and Quality Control of Ayurvedic Polyherbal Formulations. Int. J. Pharmacogn. Herb. Drug Technol. 2025, 2, 103–120. https://doi.org/10.64063/3049-1630.vol.2.issue7.9.

  • 68.

    Animish, A.; Jayasri, M.A. Standardization and Quality Control Analysis of a Polyherbal Antidiabetic Formulation. Curr. Trends Biotechnol. Pharm. 2023, 17, 1252–1270.

  • 69.

    Zhang, H.; Zhang, Y.; Zhang, T.; et al. Research Progress on Quality Markers of Traditional Chinese Medicine. J. Pharm. Biomed. Anal. 2022, 211, 114588. https://doi.org/10.1016/j.jpba.2022.114588.

  • 70.

    Jain, S.D.; Shrivastava, S.K.; Agrawal, A.; et al. WHO Guidelines for Quality Control of Herbal Medicines: From Cultivation to Consumption. Int. J. Pharm. Chem. Anal. 2024, 11, 212–225. https://doi.org/10.18231/j.ijpca.2024.031.

  • 71.

    Wang, H.; Chen, Y.; Wang, L.; et al. Advancing Herbal Medicine: Enhancing Product Quality and Safety through Robust Quality Control Practices. Front. Pharmacol. 2023, 14, 1265178. https://doi.org/10.3389/fphar.2023.1265178.

  • 72.

    Pratiwi, R.; Dipadharma, R.H.; Prayugo, I.J.; et al. Recent Analytical Method for Detection of Chemical Adulterants in Herbal Medicine. Molecules 2021, 26, 6606. https://doi.org/10.3390/molecules26216606.

  • 73.

    Tsukamoto, K.; Cnop, M.; Mori, D.; et al. Future Perspectives for the Treatment of Diabetes: Importance of a Regulatory Framework. Ther. Innov. Regul. Sci. 2019, 53, 535–541. https://doi.org/10.1177/2168479018795854.

  • 74.

    Devi, A.; Devi, R.; Kumar, S.; et al. Regulatory Status of Herbal Drugs in India. Int. J. Appl. Pharm. Sci. Res. 2022, 7, 30–35.

  • 75.

    Mehla, N. Pharmacovigilance in AYUSH: Ensuring Safety in Traditional Medicine. World J. Pharm. Res. 2025, 14, 368–395. https://doi.org/10.20959/wjpr202517-38090.

  • 76.

    Sapoliya, N.K.; Shah, M.B. Regulations on Herbal Products in India, United States and European Union: A Review. Int. J. Drug Regul. Aff. 2022, 10, 67–72. https://doi.org/10.22270/ijdra.v10i2.528.

  • 77.

    Sabale, B.Y.; Barbole, K.M.; Barbole, K.M.; et al. A Review: Current Scenario of Herbal Drug as Over-The-Counter Product. AJPTech 2025, 15, 134–140. https://doi.org/10.52711/2231-5713.2025.00022.

  • 78.

    Bailey, R.L. Current Regulatory Guidelines and Resources to Support Research of Dietary Supplements in the United States. Crit. Rev. Food Sci. Nutr. 2020, 60, 298–309. https://doi.org/10.1080/10408398.2018.1524364.

  • 79.

    Jadhav, R.; Das, J.; Rajyaguru, S.; et al. Regulations, Current Development, and Future Prospects of Phytopharmaceuticals, a New Class of Herbal Medicines in India. Discov. Pharm. Sci. 2025, 1, 6. https://doi.org/10.1007/s44395-025-00006-4.

  • 80.

    Dubale, S.; Usure, R.E.; Mekasha, Y.T. Traditional Herbal Medicine Legislative and Regulatory Framework: A Cross-Sectional Quantitative Study and Archival Review Perspectives. Front. Pharmacol. 2025, 16, 1475297. https://doi.org/10.3389/fphar.2025.1475297.

  • 81.

    Parveen, A.; Parveen, B.; Parveen, R.; et al. Challenges and Guidelines for Clinical Trial of Herbal Drugs. J. Pharm. Bioallied Sci. 2015, 7, 329–333. https://doi.org/10.4103/0975-7406.168035.

  • 82.

    Dahlén, A.D.; Dashi, G.; Maslov, I.; et al. Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales. Front. Pharmacol. 2022, 12, 807548. https://doi.org/10.3389/fphar.2021.807548.

  • 83.

    Kshirsagar, N. Post-Marketing Safety Signals: Challenges in Regulatory Decisions, Communication and Impact Evaluation in Developing Countries. Indian J. Med. Res. 2017, 146, 445–447. https://doi.org/10.4103/ijmr.IJMR_1070_17.

  • 84.

    Shetty, A.; Dubey, A.; Matcheswala, A.; et al. Pharmacovigilance Systems and Strategies: Importance of Post-Marketing Surveillance for Ensuring Drug Safety and Patient Health in Europe, United States, and India. Authorea Preprints. 2023. https://doi.org/10.22541/au.167730302.27488138/v1.

  • 85.

    Kumar, S.; Sharma, A.; Gupta, B. A Critical Review of Drug Safety and Pharmacovigilance Practices. Acta Pharma Rep. 2023, 2, 5–9. https://doi.org/10.51470/APR.2023.2.2.05.

  • 86.

    Trifirò, G.; Crisafulli, S. A New Era of Pharmacovigilance: Future Challenges and Opportunities. Front. Drug Saf. Regul. 2022, 2, 866898. https://doi.org/10.3389/fdsfr.2022.866898.

  • 87.

    Adhikari, B.I.; Venkatesh, D.N. The Nutraceutical Market: Intellectual Property, Clinical Research, and Future Insights. Int. J. Appl. Pharm. 2025, 17, 39–52. https://doi.org/10.22159/ijap.2025v17i2.53278.

  • 88.

    Shan, F.; Liu, L.; Li, L.; et al. Management, Safety, and Efficacy Evaluation of Nutraceutical and Functional Food: A Global Perspective. Compr. Rev. Food Sci. Food Saf. 2025, 24, e70222. https://doi.org/10.1111/1541-4337.70222.

  • 89.

    Aliu, T.B.; Obun, F.E.; Raji, H.; et al. Safety Evaluation and Concerns of Natural Products in Traditional Medicine. AROC Pharm. Biotechnol. 2025, 5, 9–17. https://doi.org/10.53858/arocpb05010917.

  • 90.

    Wairimu, H.K. Integrating Traditional and Modern Medicine: A Holistic Approach to Diabetes Care. Res. Invent. J. Biol. Appl. Sci. 2025, 5, 33–37. https://doi.org/10.59298/RIJBAS/2025/513337.

  • 91.

    Nguyen, P.T.; Nguyen, H.T. Emerging Trends in Pharmacological Research of Herbal-Based Traditional Medicine. Adv. Tradit. Med. 2026, 26, 305–323. https://doi.org/10.1007/s13596-025-00866-2.

  • 92.

    Ansari, M.A.; Chauhan, W.; Shoaib, S.; et al. Emerging Therapeutic Options in the Management of Diabetes: Recent Trends, Challenges and Future Directions. Int. J. Obes. 2023, 47, 1179–1199. https://doi.org/10.1038/s41366-023-01369-3.

  • 93.

    Zolkepli, H.; Widodo, R.T.; et al. A Review on the Delivery of Plant-Based Antidiabetic Agents Using Nanocarriers: Current Status and Their Role in Combatting Hyperglycaemia. Polymers. 2022, 14, 2991. https://doi.org/10.3390/polym14152991.

  • 94.

    Liu, M.; Wang, R.; Hoi, M.P.; et al. Nano-Based Drug Delivery Systems for Managing Diabetes: Recent Advances and Future Prospects. Int. J. Nanomed. 2025, 20, 6221–6252. https://doi.org/10.2147/IJN.S508875.

  • 95.

    Latif, R.; Nawaz, T. Medicinal Plants and Human Health: A Comprehensive Review of Bioactive Compounds, Therapeutic Effects, and Applications. Phytochem. Rev. 2026, 25, 2299–2342. https://doi.org/10.1007/s11101-025-10194-7.

  • 96.

    Shrivastava, R.; Modi, G.; Satpathy, P.S.; et al. Natural Products Revolutionizing and Innovative Drug Discovery and Development Strategies: Healthcare Challenges and Future Perspectives. J. Appl. Bioanal. 2024, 10, 20–38. https://doi.org/10.53555/jab.v10.002.

Share this article:
How to Cite
Sahu, S.; Patil, U. K.; Pawde, D. M. Herbal Products in Diabetes Management: Therapeutic Potential, Clinical Relevance, and Regulatory Challenges. Natural Products Analysis 2026, 2 (1), 100012. https://doi.org/10.53941/npa.2026.100012.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.